In the present study we tried to provide a preliminary answer to this question by systematically exploring the expression level of a large set of breast cancer related gene signatures derived from human tumors in samples from dog mammary tumors.
Santagata et al. [44] explored the expression levels of the ESC TFs OCT3/4, NANOG, and SOX2 in primary and metastatic germ cell tumors (GCTs).
The aim of this study is to explore the expression levels of VLDLR II in human gastric, breast and lung cancer tissues, and to investigate its relationship with clinical characteristics and β-catenin expression status.
In order to explore the expression levels of the ABC genes, 10 PCa and 6 NPT samples were profiled on human ABC transporter TLDAs containing probes for 50 ABC genes in total.
To investigate the clinical relevance of miR-125b, miR-205 and miR-424, we used RTQ-PCR to explore the expression levels of these three miRNAs in a cohort of 65 primary breast tumor samples (Additional file 1: Table S1).
The present study was performed to explore the expression level of osteoblast maker genes in human mesenchymal stem cells (hMSCs) grown on a Ca-P biomaterial.
Since the Gene Expression Commons is designed as an open platform, investigators can explore the expression level of any gene, search by expression patterns of interest, submit their own microarray data, and design their own working models representing biological relationship among samples.
After detecting some important changes in their morphological features, we explored the expression level of several genes in Escherichia coli cells adhering onto flat and nanostructured gold surfaces, detecting the activation of the two-component system stress pathways CpxP/R and the up-regulation of the fimbrial recombinase FimE.
Transcriptome sequencing (RNA-seq) and immunohistochemistry (IHC) were used to explore the expression level of key signaling pathways affected by these genetic aberrations.
